Overview
Brucella canis spondylitis is a rare but serious condition primarily affecting male dogs, though rare cases in humans have been reported. This zoonotic infection primarily involves the spine, leading to significant morbidity and mortality. The clinical presentation often includes systemic symptoms alongside localized spinal involvement. Given its rarity and the potential for severe complications, early recognition and appropriate management are crucial. This guideline synthesizes current evidence to provide clinicians with a comprehensive approach to diagnosing, managing, and monitoring patients with Brucella canis spondylitis.
Clinical Presentation
Brucella canis spondylitis predominantly affects male patients, with the mean age of reported cases being approximately 55.9 years [PMID:19378233]. The clinical presentation is often characterized by a constellation of systemic symptoms indicative of a systemic infection. Fever, reported in 60% of cases, is a hallmark sign, reflecting the body's immune response to the bacterial invasion [PMID:19378233]. Dyspnea and fatigue are also frequently observed, suggesting potential involvement of multiple organ systems or significant systemic inflammatory response. These symptoms can mimic other chronic inflammatory or infectious conditions, necessitating a high index of suspicion for zoonotic transmission, particularly in individuals with occupational exposure to dogs or a history of animal contact. Localized spinal symptoms, such as back pain, radiculopathy, and neurological deficits, may also be present, reflecting direct spinal involvement by the infection. Early recognition of these systemic and localized manifestations is critical for timely intervention.
Diagnosis
Diagnosing Brucella canis spondylitis requires a multifaceted approach given its rarity and nonspecific initial presentation. Serological testing, including agglutination tests and ELISA, plays a pivotal role in identifying antibodies against Brucella species [PMID:19378233]. However, these tests can sometimes yield false positives or negatives, necessitating confirmatory methods such as blood cultures or polymerase chain reaction (PCR) testing, which can detect the presence of Brucella DNA in clinical samples [PMID:19378233]. Imaging studies, particularly MRI and CT scans, are essential for visualizing spinal involvement, often revealing characteristic lesions such as vertebral osteomyelitis, discitis, or epidural abscesses [PMID:19378233]. Additionally, echocardiography in suspected cases can identify valvulopathy, with valve pathology observed in 70% of patients, predominantly affecting the aortic valves over the mitral valves [PMID:19378233]. This cardiovascular involvement underscores the systemic nature of the infection and the importance of comprehensive cardiac evaluation in these patients.
Management
The management of Brucella canis spondylitis is multifaceted, focusing on both antimicrobial therapy and surgical intervention when necessary. Antimicrobial therapy typically involves a combination regimen aimed at achieving high efficacy and minimizing resistance. Studies indicate that a combination of a tetracycline (such as doxycycline), rifampicin, and a third-generation cephalosporin (like ceftriaxone) yields favorable outcomes [PMID:19378233]. This regimen has been associated with a lower mortality rate of 20% compared to regimens that include aminoglycosides, which had a higher mortality rate of 33% [PMID:19378233]. The rationale behind avoiding aminoglycosides in this context may relate to their nephrotoxicity and potential for exacerbating existing organ dysfunction in critically ill patients. Duration of therapy is generally prolonged, often extending beyond the typical course for other infections, to ensure eradication of the organism and prevent relapse.
In cases where there is significant structural damage, such as severe aortic valve pathology or spinal instability, surgical intervention may be warranted. Aortic valve replacement, when combined with appropriate antibiotic therapy, has demonstrated good clinical outcomes, with a mortality rate of 20% reported in such cases [PMID:19378233]. Surgical options for spinal involvement include decompression, stabilization, and in severe cases, spinal fusion to address neurological deficits and stabilize the spine. The decision for surgery should be individualized based on the extent of spinal involvement, neurological status, and overall patient condition.
Prognosis & Follow-up
The prognosis for patients with Brucella canis spondylitis varies widely, influenced by factors such as the severity of spinal and cardiac involvement, timeliness of diagnosis, and adherence to treatment protocols. Studies report a mortality rate of 30%, highlighting the serious nature of this condition [PMID:19378233]. However, approximately 20% of patients achieve stability on medical therapy without further disease progression, underscoring the importance of early and aggressive management [PMID:19378233]. Long-term follow-up is essential to monitor for potential relapse, chronic sequelae, and late complications such as chronic arthritis or persistent cardiac valvular disease. Regular clinical evaluations, periodic imaging studies, and serological monitoring for persistent infection are crucial components of post-treatment care. Additionally, patients should be educated on the importance of completing the full course of antibiotics and avoiding re-exposure to infected animals to prevent recurrence.
Key Recommendations
References
1 Cay S, Cagirci G, Maden O, Balbay Y, Aydogdu S. Brucella endocarditis - a registry study. Kardiologia polska 2009. link
1 papers cited of 3 indexed.